Swiss reimbursement system for medical devices and IVD tests

This online on-demand seminar gives a comprehensive understanding of the hospital reimbursement landscape for medical devices in Switzerland. Additional modules cover reimbursement of IVD tests and screening methods

Provided in the form of the presentation in Acrobat PDF

Switzerland is a very attractive market for innovative medical device companies.

Easiness of creation of procedure code at the hospital level (CHOP code), high tariffs for hospital care and lack of mandatory evidence review for novel procedures makes Switzerland a very interesting market for medical device companies with hospital products.

The key challenges at the market are the development of procedure code, adjustment of DRG system (including the creation of add-on reimbursement). Also, new methods can be questioned by insurance companies and routed for national health technology assessment by the Federal Office of Public Health. In such cases, based on the manufacturer’s submission, the Office decides about coverage of the procedure in the statutory health insurance.

We offer a seminar on critical elements of the hospital reimbursement system for medical devices in Switzerland that can guide your decision-making about the introduction of novel technologies into this market.

What topics are reviewed?

Key stakeholders and their role in reimbursement processes

Key stakeholders are reviewed, including payers, policy-makers, advising organizations (including partners of SwissDRG) and support bodies (developer of procedural classification/DRG system)

Money flow and hospital payment system

Money flow and distribution of funds, an overview of the hospital payment system (DRG system), the process of development of the DRG system

Funding and health technology assessment landscape

Funding framework, including coverage of services within statutory health insurance (KLV List). HTA landscape and role of HTA in market access

Additional modules

Reimbursement system for in-vitro diagnostic tests

A separate comprehensive overview of the reimbursement system for IVD tests in Switzerland

Organization and financing of screening methods

A separate comprehensive overview of the organizational and financing framework of screening methods (e.g. breast and cervical cancer screening) in Switzerland

Technical overviews of reimbursement pathways

Details of the application process in relation to creation of procedure code (CHOP), DRG change and entering the health benefit catalogue (LKV List)

What topics are not covered?

Some topics are not specifically covered in this seminar: reimbursement model in out-patient settings, reimbursement for medical aids (devices for home use), funding of capital equipment.

Topics that are not covered in this seminar will be included in future courses. You can subscribe to our newsletter and inform us about your particular interests at the main page of the Market Access Academy.

How seminar is delivered?

Option #1: Pre-recorded webinar

One option is to watch the seminar, which is provided as a pre-recorded webinar. The duration of the webinar is 23 minutes. Webinar is available for 6 months

Option #2: Presentation in Acrobat PDF

You can also access just the educational material - the full presentation of the seminar in Acrobat PDF

View extract from the seminar

This 1-minute extract presents the overview of integration of novel procedure into DRG system

 

Request a quote

Click the button below to request a quote for the seminar

Do you have any remaining questions?

Check if they are answered at the main page or contact us
Check the main page
Close

50% Complete

Two Step

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.